DP1受体拮抗剂
| 英文名 | Laropiprant | CAS号 | 571170-77-9 |
| 试剂别名 |
MK-0524 Laropiprant;Laropiprant;2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid;Cyclopent[b]indole-3-acetic acid, 4-[(4-chlorophenyl) methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-, (3R)-;MK 0524;MK-0524;(3R)-[4-(4-chlorobenzyl)-7-fluoro-5-(methane-sulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid;[(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid;[(3R)-4-(4-chlorophenyl)methyl-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b] indol-3-yl]acetic acid;[14C]-Laropiprant;Cardaptive;(3R)-4-[(4-Chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)cyclopent[b]indole-3-acetic acid
|
分子式 | C21H19ClFNO4S |
| 产品编号 | APEA3538 | 分子量 | 435.9 |
| MDL号 |
| 产品名称： | DP1受体拮抗剂 |
| 英文名称： | Laropiprant |
| 英文别名： | MK-0524 Laropiprant;Laropiprant;2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid;Cyclopent[b]indole-3-acetic acid, 4-[(4-chlorophenyl) methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-, (3R)-;MK 0524;MK-0524;(3R)-[4-(4-chlorobenzyl)-7-fluoro-5-(methane-sulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid;[(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid;[(3R)-4-(4-chlorophenyl)methyl-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b] indol-3-yl]acetic acid;[14C]-Laropiprant;Cardaptive;(3R)-4-[(4-Chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)cyclopent[b]indole-3-acetic acid |
| 中文别名： | 拉罗皮兰，各拉西酮 |
| CAS No.： | 571170-77-9 |
| 分子式： | C21H19CLFNO4S |
| 分子量： | 435.9 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
